NuraLogix Unveils Multi-Year Cardiovascular Risk Index | AI-powered predictive insights expand the frontiers of proactive heart-health monitoring — up to 20 years into the future

NuraLogix

“Cardiovascular disease doesn’t develop overnight,” said Dr. Keith Thompson, Chief Medical Officer at NuraLogix.

← Previous
Next →
  • ABOUT
    • EDITORIAL
    • SUBMIT PRESS RELEASES
  • ADVERTISE
  • CONTACT
  • PRIVACY
    • COOKIE POLICY
  • ABOUT
    • EDITORIAL
    • SUBMIT PRESS RELEASES
  • ADVERTISE
  • CONTACT
  • PRIVACY
    • COOKIE POLICY

© 2026 All rights Reserved. Medical Device News Magazine, is a Division of PTM Healthcare Marketing, Inc.